Toggle Nav

Complete Carnitine

By The Wahls Protocol®
In Stock
PL-WAHLS-011
In stock

Complete Carnitine provides a highly stabilized form of the amino acid L-carnitine, supports cardiovascular health, pulmonary function, and muscle recovery from exercise.

L-carnitine supports fat utilization and energy production in the mitochondria and is found in abundance in heart and skeletal muscle.

Complete Carnitine contains 60% pure L-carnitine and 32% natural L-tartaric acid.

  • Supports Cardiovascular, Neurological, and Endocrine System Health*
  • Supports Fat Utilization and Energy Generation*
  • Supports Post-Exercise Muscle Recovery*
  • Provides 680 mg of Stabilized L-Carnitine per Two-Capsule Dose

Take one capsule twice daily between meals, or as directed by your healthcare practitioner.

Consult your healthcare practitioner prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Do not use if tamper seal is damaged.

DOES NOT CONTAIN: Wheat, gluten, corn, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

STORAGE: Keep closed in a cool, dry place out of reach of children

Our Review*

Carnitine is a useful adjunct for improving mitochondrial efficiency and reducing oxidative stress in the setting of neurological and psychiatric diseases. (1-3) References 1. Kidd PM. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005;10(4):268-293. 2. Marx W, Hockey M, McGuinness AJ, et al. The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review. Mult Scler Relat Disord. 2020;37:101486. 3. Pogacnik L, Ota A, Ulrih NP. An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases. Cells. 2020;9(3).